Detalhe da pesquisa
1.
DTRMWXHS-12, a novel Bruton tyrosine kinase inhibitor, in combination with everolimus and pomalidomide in patients with relapsed/refractory lymphomas: An open-label, multicenter, phase 1a/1b study.
Am J Hematol
; 98(5): 739-749, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36810799
2.
Assessment of oral bioavailability enhancing approaches for SB-247083 using flow-through cell dissolution testing as one of the screens.
Int J Pharm
; 250(1): 147-56, 2003 Jan 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-12480281